Literature DB >> 15259468

Skewing of cytokine profiles towards T helper cell type 2 response in visceral leishmaniasis patients unresponsive to sodium antimony gluconate.

C P Thakur1, D K Mitra, S Narayan.   

Abstract

Thirty-two parasitologically confirmed visceral leishmanisis (VL) patients and 23 healthy, age- and gender-matched controls were recruited between April 2001 and March 2002 and studied for intracellular cytokine production after stimulation in vitro using a Fluorescence Activated Cell Sorter-based intracellular cytokine assay. The VL patients were given i.m. sodium antimony gluconate at a dose of 20 mg/kg bodyweight daily for 28 d and were grouped as responders (n = 11) or non-responders (no response after 28 d of treatment; n = 21). Clinically, the non-responders had longer duration of illness (P < 0.05), larger spleen size (P < 0.05), and higher parasite load (P < 0.05) than responders. The percentage of T helper (Th) cells producing interferon-gamma (IFN-gamma) was significantly higher (P < 0.001) in responders than non-responders. Non-responders had higher IFN-gamma production than control subjects (P < 0.001). The percentage of Th cells producing interleukin-4 (IL-4) was significantly higher in non-responders than responders (P = 0.003) as well as in healthy subjects (P < 0.001). The frequency of IL-4 producing cells in responders and control subjects was similar (P= 0.65). The cytokine polarization index, as calculated by the formula loge IFN-gamma producing cells/loge IL-4 producing cells, was significantly lower in non-responders compared with both responders and control subjects (P = 0.003 and P < 0.001, respectively). The overall cytokine bias in non-responders was skewed towards a IL-4 dominance or Th2-like response and this was primarily due to induction of IL-4.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15259468     DOI: 10.1016/s0035-9203(03)90071-x

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  9 in total

1.  Antimony-resistant but not antimony-sensitive Leishmania donovani up-regulates host IL-10 to overexpress multidrug-resistant protein 1.

Authors:  Budhaditya Mukherjee; Rupkatha Mukhopadhyay; Bijoylaxmi Bannerjee; Sayan Chowdhury; Sandip Mukherjee; Kshudiram Naskar; Uday Sankar Allam; Dipshikha Chakravortty; Shyam Sundar; Jean-Claude Dujardin; Syamal Roy
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

2.  Leishmania donovani isolates with antimony-resistant but not -sensitive phenotype inhibit sodium antimony gluconate-induced dendritic cell activation.

Authors:  Arun Kumar Haldar; Vinod Yadav; Eshu Singhal; Kamlesh Kumar Bisht; Alpana Singh; Suniti Bhaumik; Rajatava Basu; Pradip Sen; Syamal Roy
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

3.  Linking in vitro and in vivo survival of clinical Leishmania donovani strains.

Authors:  Manu Vanaerschot; Ilse Maes; Meriem Ouakad; Vanessa Adaui; Louis Maes; Simonne De Doncker; Suman Rijal; François Chappuis; Jean-Claude Dujardin; Saskia Decuypere
Journal:  PLoS One       Date:  2010-08-17       Impact factor: 3.240

4.  Regulatory T cells suppress T cell activation at the pathologic site of human visceral leishmaniasis.

Authors:  Ambak K Rai; Chandreshwar P Thakur; Amar Singh; Tulika Seth; Sandeep K Srivastava; Pushpendra Singh; Dipendra K Mitra
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

5.  Antimonial resistance in Leishmania donovani is associated with increased in vivo parasite burden.

Authors:  Manu Vanaerschot; Simonne De Doncker; Suman Rijal; Louis Maes; Jean-Claude Dujardin; Saskia Decuypere
Journal:  PLoS One       Date:  2011-08-01       Impact factor: 3.240

6.  Identification of Clinical Immunological Determinants in Asymptomatic VL and Post Kala-azar Dermal Leishmaniasis Patients.

Authors:  Ashish Kumar Singh; Vidya Nand Rabi DAS; Ajay Amit; Manas R Dikhit; Vijaya Mahantesh; Akhilesh Kumar; Raj Kishore Pandey; Shyam Naryan; Bipin K Singh; Krishna Pandey; Neena Verma; Pradeep DAS; Sanjiva Bimal
Journal:  Iran J Parasitol       Date:  2018 Oct-Dec       Impact factor: 1.012

7.  Multifunctional, TNF-α and IFN-γ-Secreting CD4 and CD8 T Cells and CD8High T Cells Are Associated With the Cure of Human Visceral Leishmaniasis.

Authors:  Lorranny Santana Rodrigues; Aline Silva Barreto; Lays Gisele Santos Bomfim; Marcos Couto Gomes; Nathalia Luisa Carlos Ferreira; Geydson Silveira da Cruz; Lucas Sousa Magalhães; Amélia Ribeiro de Jesus; Clarisa B Palatnik-de-Sousa; Cristiane Bani Corrêa; Roque Pacheco de Almeida
Journal:  Front Immunol       Date:  2021-10-28       Impact factor: 7.561

8.  Arginase activity - a marker of disease status in patients with visceral leishmaniasis in ethiopia.

Authors:  Tamrat Abebe; Yegnasew Takele; Teklu Weldegebreal; Tom Cloke; Ellen Closs; Camille Corset; Asrat Hailu; Workagegnehu Hailu; Yifru Sisay; Karina Corware; Margaux Corset; Manuel Modolell; Markus Munder; Fabienne Tacchini-Cottier; Ingrid Müller; Pascale Kropf
Journal:  PLoS Negl Trop Dis       Date:  2013-03-28

9.  Antimony resistant Leishmania donovani but not sensitive ones drives greater frequency of potent T-regulatory cells upon interaction with human PBMCs: role of IL-10 and TGF-β in early immune response.

Authors:  Rajan Guha; Shantanabha Das; June Ghosh; Shyam Sundar; Jean Claude Dujardin; Syamal Roy
Journal:  PLoS Negl Trop Dis       Date:  2014-07-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.